Abstract:Magnetic Resonance Imaging(MRI)is a powerful method for clinical diagnosis and therapy due to the distinguishing characteristics of providing high-quality three-dimensional images of soft tissue without the need for harmful ionizing radiation.Complexes of gadolinium(Ⅲ)have proven to be especially effective M RI contrast agents,as it is estimated that they are needed for over 30% of the patients to accelerate relaxation rate of in vivo water protons,thus enhancing the contrast of different biological tissues and definition between normal tissues and diseased parts.For more sensitive small-molecule gadolinium-based M RI contrast agents,one essential requirement is to increase the hydration number q, which enhances the gadolinium's relaxivity.However,with the concern of chronic kidney disease(CKD) and nephrogenic systemic fibrosis(NSF),competition between strong chelate stability and free water coordination sites has increasingly become a challenge to M RI enhancement agent design.A highly stable N-oxide-DTPA-bisamide-based Gd(Ⅲ)complex with 3 coordinated water molecules is synthesized.The general methods such as 1 H-NMR,13C-NMR and ESI-MS spectroscopy are used to characterize the structures of the ligand and the complex.T he hydration number determined by the fluorescence lifetime of its Europium(Ⅲ)analogue is 3.M RI measurement show s much higher relaxivity value(16.39 mM -1·s-1) than commercial contrast agents.By fitting the potentiometric data with HYPERQUAD program,the formation constants of the Gd(Ⅲ)complex are calculated and demonstrated a superior stability over Gd-DTPA-BMA(Omniscan?).Meanwhile,in vivo imaging shows good imaging quality and cell tests reveal low cytotoxicity of the complexes,which indicate its great potential for future clinical applications.

High-relaxivity MRI contrast agents prepared from miniemulsion polymerization using gadolinium(III)-based metallosurfactants.

Attaching Double Chain Cationic Gd(Iii)-Containing Surfactants On Nanosized Colloids For Highly Efficient Mri Contrast Agents

Preparation of Highly Efficient Mri Contrast Agents Through Complexation of Cationic Gd-Iii-Containing Metallosurfactant with Biocompatible Polyelectrolytes

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents

Formation of Nanosized Gd(III) Coordination Networks with Tripodal Amine-N-oxide Type Ligand Through Microemulsions to Achieve High Relaxivity and Exceptional Stability for MRI Applications

Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High 1H Relaxivity

Easy preparation of an MRI contrast agent with high longitudinal relaxivity based on gadolinium ions-loaded graphene oxide

Hyperbranched Polyethylenimine Based Polyamine-N-Oxide-Carboxylate Chelates of Gadolinium for High Relaxivity Mri Contrast Agents

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

HP-DO3A-based Amphiphilic MRI Contrast Agents and Relaxation Enhancement Through Their Assembly with Polyelectrolytes.

Co‐Assembly of Gd(III)‐Based Metallosurfactant and Conjugated Polymer Nanoparticles in Organosilica Cross‐Linked Block Copolymer Micelles for Highly Efficient MRI and Fluorescent Bimodal Imaging

The research progress of gadolinium(iii)-based macromolecular mri contrast agents

Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane As a Long Circulating High Relaxivity MRI Contrast Agent

High Relaxivity Trimetallic Nitride (gd3n) Metallofullerene Mri Contrast Agents with Optimized Functionality

THE RESEARCH PROGRESS OF GADOLINIUM(Ⅲ)-BASED MACROMOLECULAR MRI CONTRAST AGENTS

Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

High Relaxivity Gadolinium-Polydopamine Nanoparticles.

Application of Gd(III) Complexes for Magnetic Resonance Imaging and the Improvement of Relaxivities Via Nanocrystallization

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent